MedTrace Logo

Thulium Fiber Laser Prospective Trial

NCT05814133 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-01-31

No results posted yet for this study

Summary

This is a multi-center, prospective clinical trial to assess the effect of TFL for the lithotripsy of kidney stones.

Conditions

  • Kidney Stone

Interventions

DEVICE

Thulium Fiber Laser

Thulium Fiber Laser will be used to break renal stones \< 2 cm into fragments small enough to remove or pass spontaneously through the ureter.

Sponsors & Collaborators

  • University of British Columbia

    collaborator OTHER

  • Columbia University

    collaborator OTHER

  • University of California, San Diego

    collaborator OTHER

  • Mayo Clinic

    collaborator OTHER

  • Ohio State University

    collaborator OTHER

  • Vanderbilt University

    collaborator OTHER

  • The Cleveland Clinic

    collaborator OTHER

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Naeem Bhojani, MD · Centre hospitalier de l'Université de Montréal (CHUM)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2025-01-15
Completion
2025-07-15

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05814133 on ClinicalTrials.gov